Flagship Pioneering Special Opportunities Fund II General Partner LLC

Related Filers (16)

Other (8)

13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
Show More

Ownership (6)

4
Thursday, 8/5/2021
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Omega Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/10/2020
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Sigilon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/29/2020
Foghorn Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/22/2020
Foghorn Therapeutics Inc.: Initial statement of beneficial ownership of securities
Show More